RICC A/S: Financial statements 2025
CVR: 20690003
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
RICC A/S (CVR 20690003) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 91,000 and a net result of DKK 160,586,000 compared with DKK 730,000 the year before. That is a decrease of 93.1% compared with the year before. Equity in the 2025 report amounted to DKK 163,015,000. The solvency ratio was 99.8%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 91,000
- Profit/Loss
- DKK 160,586,000
- Equity
- DKK 163,015,000
- Total Assets
- DKK 163,353,000
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 91 t. | 160.6 mio. | 163 mio. | 5 |
| 2024 | - | 1.3 mio. | 730 t. | 2.4 mio. | 5 |
| 2023 | - | 77 mio. | -2.8 mio. | 1.7 mio. | 42 |
| 2022 | - | 210.2 mio. | 9.3 mio. | 4.5 mio. | 57 |
| 2021 | - | 133.7 mio. | 4.5 mio. | -4.9 mio. | 70 |
Official annual report
How creditworthy is RICC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
RICC A/S has published its annual report for 2024. Gross profit came to DKK 1,314,000, and the net result was DKK 730,000.
As of July 1, 2025, Carole Hassoun has joined the board of directors of RICC A/S.
As of July 1, 2025, Maria Falkenberg Petersen has left the board of directors of RICC A/S.
As of July 1, 2025, Carole Hassoun is registered as adm. dir. of RICC A/S.
As of July 1, 2025, Maria Falkenberg Petersen has stepped down as adm. dir. of RICC A/S.
As of April 14, 2025, Maria Falkenberg Petersen is registered as adm. dir. of RICC A/S.
As of April 14, 2025, Darine Ghanem has stepped down as adm. dir. of RICC A/S.
As of April 8, 2025, Maria Falkenberg Petersen has joined the board of directors of RICC A/S.
As of April 8, 2025, Darine Ghanem has left the board of directors of RICC A/S.
About RICC A/S
RICC A/S is a Danish company of the type Aktieselskab based in København V, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ROCHE INNOVATION CENTER COPENHAGEN A/S and SANTARIS PHARMA A/S. The management consists of Carole Hassoun. The board consists of Sylke Pöhling (chair), Carole Hassoun and Isabel Marianne Joerin. The company is owned by F. Hoffmann-La Roche Ltd. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK 91,000 and a net result of DKK 160,586,000 compared with DKK 730,000 the year before. Equity in the 2025 report amounted to DKK 163,015,000.